SIDE-BY-SIDE EVIDENCE

Compare evidence.
Keep the context.

Select 2–3 profiles from the English Library. Class and grade describe evidence and regulatory context, not comparative effectiveness or suitability for an individual.

Choose profiles

SIDE-BY-SIDE EVIDENCE VIEW

Compare selected profiles

Evidence comparison · not a treatment ranking

Evidence boundaries, not cross-trial treatment outcomes
Molecule	Estradiol cypionate	Testosterone	Tamoxifen
Research Topic	Clinical / Endocrine Pharmacology	Clinical / Endocrine Pharmacology	Clinical / Endocrine Pharmacology
Pharmacology	Long-acting estrogen ester in product-specific prescription contexts	Endogenous androgen / prescription androgen medicine	Selective estrogen receptor modulator medicine
PrimeCore Class	Class AApproved in a bounded context	Class AApproved in a bounded context	Class AApproved in a bounded context
Evidence Grade	Grade AStrong regulatory + clinical evidence	Grade AStrong regulatory + clinical evidence	Grade AStrong regulatory + clinical evidence
Evidence boundary	Estradiol cypionate is classified here as Long-acting estrogen ester in product-specific prescription contexts. Prescription evidence exists for defined hormone-therapy products; it does not authenticate a catalogue vial. Product-specific prescription labels exist in the United States; exact supplier identity, formulation and Thai authorisation remain unverified. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions.	Testosterone is an endogenous androgen and an active ingredient in authorised prescription medicines, but 'Test' does not identify an ester, formulation, strength, manufacturer or authorisation. Cypionate, enanthate, undecanoate, propionate, no-ester formulations and blends are not automatically interchangeable. TRAVERSE found MACE noninferiority for a specific gel in a defined population while other safety signals remained. This evidence does not authenticate catalogue products or support performance use. WADA 2026 prohibits testosterone and its esters at all times.	Tamoxifen is classified here as Selective estrogen receptor modulator medicine. Large controlled oncology evidence supports product-specific breast-cancer indications and prevention contexts. FDA-authorised prescription products exist for defined oncology contexts; WADA prohibits SERMs at all times. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions.
Unknowns	Insufficient data in the current dataset	Insufficient data in the current dataset	Insufficient data in the current dataset
Limitations	Estradiol cypionate molecule or active moiety ≠ ester/salt ≠ formulation ≠ brand ≠ supplier product; biological plausibility or historical use ≠ current approval ≠ safe performance use	Testosterone molecule ≠ ester ≠ formulation ≠ brand ≠ supplier product; treatment evidence ≠ performance use; noninferiority in TRAVERSE ≠ absence of every cardiovascular or thrombotic risk	Tamoxifen molecule or active moiety ≠ ester/salt ≠ formulation ≠ brand ≠ supplier product; biological plausibility or historical use ≠ current approval ≠ safe performance use
Sources	DailyMed · Estradiol cypionate human drug-label inventory FDA · Why unapproved drugs require product-specific review WADA · 2026 Prohibited List	FDA · Testosterone Information · updated June 2026 DailyMed · Testosterone cypionate injection label WADA · 2026 Prohibited List TRAVERSE cardiovascular-safety trial · PMID 37326322 FDA class-wide labeling changes · 2025–2026	DailyMed · Tamoxifen human drug-label inventory FDA · Why unapproved drugs require product-specific review WADA · 2026 Prohibited List
Read more	Read English overview Complete evidence profile (Thai)	Read English overview Complete evidence profile (Thai)	Read English overview Complete evidence profile (Thai)

This table does not compare doses, cross-trial outcomes or individual suitability. Missing information does not establish an absence of risk.

Choose another comparison

Continue reading

Missing fields mean information is unavailable in the current structured dataset, not that a molecule has no risks or uncertainties. English translations retain the original evidence boundaries. Where translation is not yet verified, the original Thai excerpts remain available under an explicit label. Sources retain their original language.

10 questions before drawing conclusions

Compare evidence.Keep the context.

Continue reading

Contact PrimeCoreBio

Compare evidence.
Keep the context.